Tuberculosis News and Research

Latest Tuberculosis News and Research

CHMP recommends approval of Otsuka's Deltyba for pulmonary multidrug-resistant tuberculosis

Otsuka Pharmaceutical Co., Ltd. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Deltyba (delamanid) in combination with a WHO recommended optimized background regimen for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB). The CHMP opinion will help form the basis for a European Commission decision expected early next year.

25 Nov 2013

Bangladesh outperforms Asian neighbours despite low spending on health care

Exceptional improvements in the survival of infants and children under 5 years of age, life expectancy, immunisation coverage, and tuberculosis control in Bangladesh are part of a remarkable success story for health in the South Asian country, according to a major new Series published in The Lancet. This is despite low spending on health care, a weak health system, and widespread poverty.

21 Nov 2013

Call to recognize lung diseases as leading causes of morbidity and mortality

Experts from the world's leading lung organisations have come together for the first time to call for a worldwide effort to improve healthcare policies, systems and care delivery to make a positive difference to the lung health of the world.

20 Nov 2013

Advanced cytotoxins help bacteria survive antibiotics treatment

In spite of the fact that the first antibiotics were discovered almost a century ago, infectious diseases such as tuberculosis, encephalitis and meningitis are still serious diseases for humans in the twenty-first century. The World Health Organization (WHO) estimates that there are more than 8 million new cases of tuberculosis per year on a global scale, and that more than 300,000 of these are due to multidrug-resistant strains that are not only difficult to treat, but are also emerging rapidly in regions such as Eastern Europe.

20 Nov 2013

WHO continues to coordinate deployment of foreign medical teams in Philippines

More than 10 days after Super Typhoon Haiyan devastated the central Philippines, WHO is continuing to coordinate the deployment of foreign medical teams with an immediate focus on injured and traumatized survivors and an eye towards the people's longer-term health needs.

20 Nov 2013

ORC to develop paper-based sensors to detect biomarkers in cancer patients

Pioneering research by the Optoelectronics Research Centre that could transform the care of cancer patients or people with infections in their own homes has received a significant grant from the Engineering and Physical Sciences Research Council.

19 Nov 2013

New biomedical instrument anticipated to help breakthroughs in animal, human health

A Kansas State University team recently received a nearly $1.3 million grant from the National Science Foundation's Major Research Institute for a biomedical instrument that is anticipated to help with breakthroughs in animal and human health as well as cancer treatment.

13 Nov 2013

Global Coalition Against Child Pneumonia calls for continued investment in innovations, proven tools

Global health advocates today commemorated the fifth annual World Pneumonia Day by calling on global leaders to scale up existing interventions and invest in new diagnostics and treatments to defeat pneumonia. Each year, pneumonia kills more children than AIDS, malaria and tuberculosis combined. Pneumonia took the lives of nearly 1.1 million children under 5 in 2012 alone, with more than 99 percent of these deaths in developing countries, where access to healthcare facilities and treatment is out of reach for many children.

12 Nov 2013

Clinical testing expanded for vaccine against latent TB

Statens Serum Institut and Aeras today announced the initiation of a Phase I/IIa clinical trial for a candidate tuberculosis vaccine designed to protect people, especially those latently infected with TB, from developing active TB disease.

8 Nov 2013

GHIT Fund makes new investments in potential treatments for malaria, tuberculosis and Chagas disease

The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.

8 Nov 2013

Longer looks: Bad behavior treatment; end of life decisions

Every week reporter Ankita Rao selects interesting reading from around the Web.

8 Nov 2013

GHIT Fund grants US$5.7 million to six global partnerships working on vaccines against malaria

The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.

8 Nov 2013

New hand-held device can help prevent thousands of unnecessary TB deaths

Thousands of deaths from tuberculosis, an infectious bacterial disease, could be prevented using a new hand-held device that is being developed to detect potentially fatal drug resistance in less than 15 minutes.

7 Nov 2013

Stop L.A. Corruption: A new awareness campaign that highlights failures of LA County

Health and public policy advocates from AIDS Healthcare Foundation (AHF) will unveil 'Stop L.A. Corruption,' a new advocacy and awareness campaign highlighting the profound failures of Los Angeles County and its key elected and appointed officials in carrying out their sworn duties to serve and protect the nearly 10 million residents of the County.

4 Nov 2013

Once-daily prescription medicine for COPD now available throughout the U.S.

GlaxoSmithKline plc and Theravance, Inc. today announced that BREO ELLIPTA, a once-daily prescription medicine for chronic obstructive pulmonary disease, is now available to pharmacies throughout the U.S.

30 Oct 2013

TB Alliance, Svizera Europe partner to create, enable access to new medicines for childhood TB

In an effort to develop and deliver treatments for children with tuberculosis—answering a critical need in public health today—TB Alliance, a not-for-profit organization with the mission to develop better, faster-acting, and affordable drugs for TB, has entered into a collaboration with Svizera Europe, one of the leading global supply and distribution companies for TB treatments.

30 Oct 2013

Reduce tobacco consumption, reduce childhood asthma

A scientific study recently published on International Journal of Statistics in Medical Research states that tobacco consumption must be decreased by 15% in Spain, particularly at home, in order to reduce the number of childhood asthma cases.

30 Oct 2013

Study looks at the feasibility of Xpert test for TB in real-life clinical setting in southern Africa

The first randomised trial to measure the impact of the rapid Xpert MTB/RIF test for tuberculosis in a real-life clinical setting finds that it can be accurately performed by a non-specialist with minimal training, improves same-day diagnosis and time to starting treatment, and increases the number of people who start treatment after testing positive on day 1 by 50%, compared with conventional TB diagnostics.

30 Oct 2013

Researchers complete first phase of landmark study on fungal complications of TB

The first phase of a landmark study of complications of tuberculosis - the first ever carried out in Africa - has been completed by researchers at Wythenshawe Hospital and the University of Manchester working with colleagues in Uganda.

30 Oct 2013

Phase 3 study shows STELARA inhibits structural damage in patients with active psoriatic arthritis

New findings from two integrated Phase 3 Janssen Research & Development, LLC (Janssen)-sponsored studies showed treatment with STELARA- (ustekinumab) resulted in significantly greater inhibition of structural damage in patients with active psoriatic arthritis compared with placebo.

29 Oct 2013

Tuberculosis News and Research

Latest Tuberculosis News and Research

CHMP recommends approval of Otsuka's Deltyba for pulmonary multidrug-resistant tuberculosis

Bangladesh outperforms Asian neighbours despite low spending on health care

Call to recognize lung diseases as leading causes of morbidity and mortality

Advanced cytotoxins help bacteria survive antibiotics treatment

WHO continues to coordinate deployment of foreign medical teams in Philippines

ORC to develop paper-based sensors to detect biomarkers in cancer patients

New biomedical instrument anticipated to help breakthroughs in animal, human health

Global Coalition Against Child Pneumonia calls for continued investment in innovations, proven tools

Clinical testing expanded for vaccine against latent TB

GHIT Fund makes new investments in potential treatments for malaria, tuberculosis and Chagas disease

Longer looks: Bad behavior treatment; end of life decisions

GHIT Fund grants US$5.7 million to six global partnerships working on vaccines against malaria

New hand-held device can help prevent thousands of unnecessary TB deaths

Stop L.A. Corruption: A new awareness campaign that highlights failures of LA County

Once-daily prescription medicine for COPD now available throughout the U.S.

TB Alliance, Svizera Europe partner to create, enable access to new medicines for childhood TB

Reduce tobacco consumption, reduce childhood asthma

Study looks at the feasibility of Xpert test for TB in real-life clinical setting in southern Africa

Researchers complete first phase of landmark study on fungal complications of TB

Phase 3 study shows STELARA inhibits structural damage in patients with active psoriatic arthritis

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in